Enap-H tablets

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

enalapril (enalapril maleate), hydrochlorothiazide

Available from:

KRKA d.d.

ATC code:

C09BA02

INN (International Name):

enalapril (enalapril maleate), hydrochlorothiazide

Dosage:

10mg+ 25mg

Pharmaceutical form:

tablets

Units in package:

(20/2x10/) in blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-02-10

Patient Information leaflet

VOL:
I;P:
_110/475_
SPC,
Labelin
1.3.1
HHCTPYKUIIJI
no
Me.lUiUHHCKOMY
npHMeHeHHfO
neKapCTBeHHoro
Cpe}lCTBa
(O}lHOBpeMeHHo
nHCTOK-
BKJIa}lblW)
3Han®-H
TaGneTKH
10
Mr
_1_
25
Mr
ToprOBoe
HalBaHHe
3Han®-H
(Enap®-H)
Me*JlYR8pO}lROe
RenaTeRTOB8RRoe
H81BaRRe
Enalapril
/
Hydrochlorothiazide
I.
:1
f
f,
u'r
r. ~.
,s
v
~
I;
i ~
J
S
eOnaB
E ~
p ~
R T /
~ !, 1 A_
_~/r._
_01 /.{_
":~L!
r.
,.~
'~
I
T
I
__~ti'._
_0/,&_
JIeK8pnBeRRail
c1topMa
TaGneTrGf
Ka>l<}lrul
Ta6rreTKa
CO}lep:lKHT
10
Mr
3HaJIanpHna
MaJIeaTa
H
25
Mr
rH}lp0XJ10pTHa3H}la.
_Bcno.wozameJlbHble 6eUlecm6a:_
HaTplIJl
rH}lpOKap60HaT,
KpacHTenb
XHHonHHOBblH
)f(enT!.IH
(E 104),
naKT03bl
MOHOrH}lpaT,
KpaxMaJI
KYKYPY3HbIH,
KpaXMaJI
npe)f(eJ1aTHHH3HpoBaHHbIH,
TaJIbK,
MarHH.II
CTeapaT.
OnHC8RHe
KpyrrrbJe,
nJIOCKHe
Ta6rreTKH
)f(eJITOro
UBeTa,
co
CKOWeHHblMH
KpaJlMH
H HaCeqKOH
Ha
OJlHOH
CTopOHe.
Hace,{Ka
He npe}lHa3Ha'{eHa}lJ1J1
}lerreHHJI
Ta6neTKH
Ha '{aCTH.
cJ)apMalConpaneBTR'IeCKaR
rpynna
I1HrH6HTopbl
ATI
B KOM6HHaUHH
C JlHYpeTHKaMH.
KO}l
A
TX:
C09BA02.
cJ)apMaICOJlOI'R"IeCICHe cBoiicTBa
_(f>apMaKoouHOMuKa_
KOM6J.1HJ.lpOBaHRbIH
npenapaT,
}leHcTBHe
KOToporo
o6YCJI0BJ1eHO
CBoHcTBaMH
KOMnOHeRTOB,
BXO)1J1IUHX B ero
COCTaB.
_3HaJlanpUlla Maneam_
3HananpHJI
JlBJUleTCJI
HHrH6HTopOM
An.
B
opraRH3Me
OR
6b1cTPO
MeTa6onH3HpYeTCJI
B
:3HaJlanpHJlaT,
KOTOPbrH
lIBJ1J1eTClI
CHnbHblM
HHrn6HTopoM
ATIll>.
OCHOBHble
3cpcpeKTbl
IofHrll6HpOBaHHJI
An:
CHH)f(eHHe
KOHueRTPaUHH
aHrHOTeH3HHa
II
H
aJIb)1oCTepORa
B
UHpl

Read the complete document

Summary of Product characteristics

PI_Text005187_1
– Updated:
Page 1 of 18
1.
NAME OF THE MEDICINAL PRODUCT
Enap
®
-H 10 mg/25 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Enap-H 10 mg/25 mg tablet contains 10 mg enalapril maleate, which
is equivalent to 7.64 mg
enalapril, and 25 mg hydrochlorothiazide.
Excipients:
lactose
114.02 mg
quinolone
yellow (E104)
0.06 mg
sodium
5.1 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Enap-H 10 mg/25 mg tablets: yellow, round, flat, scored on one side
with beveled edges.
The score
line is not intended for breaking the tablet.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Arterial hypertension (patients for whom the combination therapy is
prescribed).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The drug is intended for oral treatment.
The dosage of the drug is based primarily on the experience with its
active substance enalapril
maleate.
The usual dose is one tablet once daily. If required, the dose may be
increase to two tablets once daily.
For most patients, 20 mg (exceptionally 40 mg) enalapril maleate or 50
mg hydrochlorothiazide a day
is sufficient; therefore, not more than two Enap-H 10 mg/25 mg tablets
a day are recommended. If no
satisfactory response is achieved, addition of a second drug or
changed therapy is recommended (see
sections 4.3, 4.4, 4.5 and 5.1).
_Prior diuretic therapy_
Symptomatic hypotension may occur following the initial dose of the
drug; this is more likely in
patients who are volume and/or salt depleted as a result of prior
diuretic therapy. The diuretic therapy
should be discontinued for 2-3 days prior to initiation of therapy
with Enap-H 10 mg/25 mg.
_Dosage in renal insufficiency_
Thiazide diuretics may not be appropriate for patients with renal
impairment. They are ineffective in
patients with creatinine clearance values of 0.5 ml/s or less (i.e.
moderate and severe renal
insufficiency).
CONFIDENTIAL
Enap-H 10 mg/25 mg tablet, Enap-HL 10 mg/12.5 mg
tablet
VOL: 1; P: 44 / 792
PI_Text005187_1
– Updated:
Page 2 of 18
In pat